Insmed reported $562.86M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acelrx Pharmaceuticals ACRX:US $ 9.37M 1.89M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cytokinetics CYTK:US $ 127.89M 3.88M
Dynavax Technologies DVAX:US $ 219.96M 40.07M
Flexion Therapeutics FLXN:US $ 220.02M 14.99M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Insmed INSM:US $ 562.86M 186.87M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NVS:US $ 26491M 908M
Regeneron Pharmaceuticals REGN:US $ 1979.2M 0.3M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M